Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$470.08 USD

470.08
1,446,023

+0.27 (0.06%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $470.60 +0.52 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (148 out of 244)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen

by Zacks Equity Research

Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen are included in this Analyst Blog.

Indrajit Bandyopadhyay headshot

5 Medical Device Stocks That Survived the 2024 Market Volatility

by Indrajit Bandyopadhyay

Here, we discuss five medical device stocks, namely ISRG, GMED, GKOS, VCYT and INGN, which gained in 2024 despite ongoing challenges and provide an attractive investment opportunity for 2025.

Zacks Equity Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

Zacks Equity Research

Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock?

by Zacks Equity Research

Investors need to pay close attention to Intuitive Surgical (ISRG) stock based on the movements in the options market lately.

Zacks Equity Research

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Indrajit Bandyopadhyay headshot

ISRG Stock Reaches All-Time High: Strength in Uptrend to Continue?

by Indrajit Bandyopadhyay

Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The has stock also gained during the past month. Let's see if the trend might change.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

by Zacks Equity Research

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $549.80, marking a +1.49% move from the previous day.

Zacks Equity Research

Intuitive Surgical (ISRG) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Here's Why Retaining Cigna Stock is a Smart Move for Investors Now

by Zacks Equity Research

CI is well-poised for growth on the back of strong contributions from the Evernorth and Cigna Healthcare units. A strong financial position enables it to undertake business investments.

Zacks Equity Research

Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now

by Zacks Equity Research

ISRG's strength in robotics continues to raise optimism among investors.

Zacks Equity Research

Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?

by Zacks Equity Research

The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Equity Research

Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?

by Zacks Equity Research

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Thermo Fisher (TMO) Down 7.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nalak Das headshot

5 Non-Tech Nasdaq Composite High Flyers to Buy for More Gains Ahead

by Nalak Das

These five stocks have provided 50% returns year to date. Despite the rally, their favorable Zacks Rank indicates more room to run. The stocks are: AXON, UAL, ISRG, SFM, FOX.

Zacks Equity Research

Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View

by Zacks Equity Research

MDT delivers diversified growth across all its segments in the second quarter of fiscal 2025.

Zacks Equity Research

Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Intuitive Surgical, Inc. (ISRG) and Atossa Genetics Inc. (ATOS) have performed compared to their sector so far this year.

Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Indrajit Bandyopadhyay headshot

Will ISRG Stock Continue Its Uptrend After Gaining 9.9% in a Month?

by Indrajit Bandyopadhyay

Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The stock also gained during the past month. Let's see if the trend might change.

Zacks Equity Research

National Vision Q3 Earnings Top Estimates, Revenues Lag, Stock Tumbles

by Zacks Equity Research

EYE's third-quarter 2024 results reflect ongoing strength in Managed Care, with growth in America's Best stores.

Zacks Equity Research

Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand

by Zacks Equity Research

HAE delivers impressive growth in the top and bottom lines in the second quarter of fiscal 2025.

Zacks Equity Research

Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?

by Zacks Equity Research

The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks Equity Research

QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up

by Zacks Equity Research

QGEN delivers another solid performance in the third quarter of 2024, with both the top and bottom lines surpassing estimates.

Zacks Equity Research

Phibro's Q1 Earnings Top Estimates, Stock Up, Net Sales Surge Y/Y

by Zacks Equity Research

PAHC delivers strong growth across all its segments in the first quarter of fiscal 2025.

Zacks Equity Research

CVS Health Q3 Earnings & Revenues Beat, Stock Rises in Premarket

by Zacks Equity Research

CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

Zacks Equity Research

Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut

by Zacks Equity Research

EXAS' third-quarter 2024 top line benefits from broad-based momentum in Cologuard adoption and Oncotype DX's international expansion.